Anthropic reveals it is developing its own experimental drugs using Claude
Polymarket · x · 2026-10-28
Polymarket relays the news: Anthropic says it is developing its own experimental drugs with Claude, targeting rare childhood diseases and multiple cancers — a first among frontier AI labs.
Related event: Anthropic Uses Claude to Develop Its Own Experimental Drugs(2 posts)→
More from Companies & People
- Critic coins 'cringelabs' to mock giotto_ai's dubious 'sovereign AI' pitch — tensorqt · 2026-10-28
- Ed Zitron's 20-month-old Anthropic bearish calls resurfaced as a cautionary tale — nptacek · 2026-10-28
- KHIPU 2027 opens call for workshops, proposals due November 6, 2026 — NandoDF · 2026-10-28
- IEEE Spectrum interviews Google DeepMind's resident philosopher on AI autonomy, safety, human-AI relations — dioscuri · 2026-10-28
- 13 Weeks, 1,701 Posts: OpenAI Sentiment Stuck at 4.9/10 Until Terra Launch — kraios · 2026-10-28
- UvA Amsterdam opens funded AI4Science PhD/Postdoc positions via ELLIS, deadline Oct 31 — windx0303 · 2026-10-28